Endocannabinoid System Clinical Research: Cannabis DKJ127 Trial
The Cannabis DK127 clinical trial demonstrated significant pain reduction in chronic low back pain patients using the full-spectrum cannabis extract VER-01. This phase 3 study showed sustained benefits over 12 weeks compared to placebo. The trial…
Tirzepatide vs Liraglutide: Clinical Evidence & Research
This article presents a tirzepatide liraglutide clinical comparison based on recent trial data. It highlights differences in efficacy and safety profiles between these GLP-1 receptor agonists. Understanding this comparison aids clinicians in optimizing…
GLP-1 Receptor Agonist Clinical Evidence: Semaglutide Efficacy
This article reviews synthetic semaglutide efficacy based on recent GLP-1 receptor agonist clinical evidence. The data shows comparable glycemic control to branded Ozempic in type 2 diabetes. Understanding this efficacy helps clinicians optimize…
AM Study Update: Full-Spectrum Cannabis Extract for Chronic Pain
This AM Study Update covers the latest research on full-spectrum cannabis extract chronic pain treatment. The phase 3 trial of Cannabis sativa extract DKJ127 shows promising results for chronic low back pain. Clinicians can use this evidence to guide…
AM Study Update: March 16, 2026
This cannabis research clinical update from March 16, 2026, summarizes 20 key studies from PubMed prioritized by clinical relevance. The update covers evidence on cannabis for chronic pain, anxiety, and adolescent health. Clinicians will find valuable…
AM Study Update: March 15, 2026
This AM Study Update presents cannabis clinical trials evidence from March 15, 2026, focusing on recent research findings. The report covers safety and efficacy data for various cannabis therapies. Clinicians can use this evidence to inform patient care…
AM Study Update: March 11, 2026
This AM Study Update highlights cannabis clinical research 2026 with 20 prioritized studies from PubMed. The update covers clinical trials and systematic reviews relevant to cannabis medicine. Clinicians will find evidence-based insights for March 11,…
Medical Cannabis Evidence-Based Care: Phase 3 Trial Results
This phase 3 cannabis trial chronic low back pain study evaluated the full-spectrum cannabis extract VER-01 in 820 adults. The trial demonstrated significant pain reduction over 12 weeks with sustained effects. These results provide important evidence…